• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Retracted: -Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.撤回：μ-阿片受体激动剂U50448H通过CAP-NLRP3信号通路对体外循环大鼠急性肺损伤具有保护作用。
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9898067. doi: 10.1155/2023/9898067. eCollection 2023.
2
-Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.阿片受体激动剂U50448H通过CAP-NLRP3信号通路对体外循环大鼠急性肺损伤具有保护作用。
Evid Based Complement Alternat Med. 2022 Aug 18;2022:2868135. doi: 10.1155/2022/2868135. eCollection 2022.
3
Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway.κ 阿片受体激动剂 U50448H 通过激活 PI3K/Akt 信号通路保护大鼠肾缺血再灌注损伤。
Acta Pharmacol Sin. 2018 Jan;39(1):97-106. doi: 10.1038/aps.2017.51. Epub 2017 Aug 3.
4
Reversing Postcardiopulmonary Bypass Associated Cognitive Dysfunction Using -Opioid Receptor Agonists to Regulate Microglial Polarization via the NLRP3/Caspase-1 Pathway.逆转体外循环后认知功能障碍：阿片受体激动剂通过 NLRP3/Caspase-1 通路调节小胶质细胞极化。
J Healthc Eng. 2021 Oct 1;2021:3048383. doi: 10.1155/2021/3048383. eCollection 2021.
5
Retracted: Reversing Postcardiopulmonary Bypass Associated Cognitive Dysfunction Using -Opioid Receptor Agonists to Regulate Microglial Polarization via the NLRP3/Caspase-1 Pathway.撤稿：使用μ-阿片受体激动剂通过NLRP3/半胱天冬酶-1途径调节小胶质细胞极化来逆转体外循环相关认知功能障碍
J Healthc Eng. 2023 Oct 4;2023:9813236. doi: 10.1155/2023/9813236. eCollection 2023.
6
Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR/NLRP3 Signaling Pathway.撤回：罗格列酮通过PPAR/NLRP3信号通路减轻大鼠造影剂诱导的急性肾损伤。
Dis Markers. 2023 Jul 26;2023:9826918. doi: 10.1155/2023/9826918. eCollection 2023.
7
Retracted: -Opioid Receptor Agonist Ameliorates Postoperative Neurocognitive Disorder by Activating the Ca/CaMKII/CREB Pathway.
J Healthc Eng. 2022 Dec 11;2022:9841213. doi: 10.1155/2022/9841213. eCollection 2022.
8
κ-opioid receptor agonists may alleviate intestinal damage in cardiopulmonary bypass rats by inhibiting the NF-κB/HIF-1α pathway.κ-阿片受体激动剂可能通过抑制NF-κB/HIF-1α信号通路减轻体外循环大鼠的肠道损伤。
Exp Ther Med. 2020 Jul;20(1):325-334. doi: 10.3892/etm.2020.8685. Epub 2020 Apr 23.
9
Retracted: -Opioid Receptors Improve Vascular Endothelial Dysfunction in Salt-Sensitive Hypertension via PI3K/Akt/eNOS Signaling Pathway.撤回：μ-阿片受体通过PI3K/Akt/eNOS信号通路改善盐敏感性高血压中的血管内皮功能障碍。
Oxid Med Cell Longev. 2023 Aug 2;2023:9817815. doi: 10.1155/2023/9817815. eCollection 2023.
10
Retracted: Observation of Curative Effect of Lung Recruitment in Patients with Acute Respiratory Distress Syndrome after Cardiopulmonary Bypass Surgery.撤回：体外循环心脏手术后急性呼吸窘迫综合征患者肺复张疗效观察。
Appl Bionics Biomech. 2023 Aug 16;2023:9795374. doi: 10.1155/2023/9795374. eCollection 2023.

本文引用的文献

1
-Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.阿片受体激动剂U50448H通过CAP-NLRP3信号通路对体外循环大鼠急性肺损伤具有保护作用。
Evid Based Complement Alternat Med. 2022 Aug 18;2022:2868135. doi: 10.1155/2022/2868135. eCollection 2022.

撤回：μ-阿片受体激动剂U50448H通过CAP-NLRP3信号通路对体外循环大鼠急性肺损伤具有保护作用。

Retracted: -Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.

作者信息

And Alternative Medicine Evidence-Based Complementary

出版信息

Evid Based Complement Alternat Med. 2023 Jun 21;2023:9898067. doi: 10.1155/2023/9898067. eCollection 2023.

DOI:10.1155/2023/9898067
PMID:37388002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10307214/
Abstract

[This retracts the article DOI: 10.1155/2022/2868135.].

摘要

[本文撤回文章DOI: 10.1155/2022/2868135。]